"location_id","location","disease","time","age_group_id","age_group","age","is_filled","gender_id","gender","measure_id","measure","mean","lower","upper"
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",5,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",5,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",5,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",5,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",6,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",6,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",6,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",6,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",7,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",7,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",7,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",7,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",8,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",8,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",8,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",8,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",9,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",9,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",9,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",9,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",5,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",5,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",5,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",5,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",6,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",6,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",6,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",6,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",7,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",7,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",7,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",7,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",8,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",8,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",8,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",8,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",9,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",9,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",9,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,6,"5-9 years",9,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",10,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",10,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",10,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",10,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",11,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",11,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",11,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",11,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",12,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",12,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",12,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",12,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",13,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",13,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",13,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",13,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",14,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",14,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",14,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",14,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",10,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",10,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",10,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",10,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",11,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",11,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",11,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",11,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",12,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",12,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",12,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",12,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",13,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",13,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",13,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",13,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",14,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",14,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",14,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,7,"10-14 years",14,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",15,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",15,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",15,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",15,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",16,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",16,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",16,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",16,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",17,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",17,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",17,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",17,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",18,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",18,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",18,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",18,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",19,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",19,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",19,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",19,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",15,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",15,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",15,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",15,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",16,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",16,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",16,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",16,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",17,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",17,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",17,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",17,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",18,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",18,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",18,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",18,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",19,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",19,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",19,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,8,"15-19 years",19,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",20,TRUE,1,"Male",5,"prevalence",5.923576734e-07,5.353559927e-07,6.535833343e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",20,TRUE,1,"Male",6,"incidence",1.747797262e-07,1.570389282e-07,1.915613877e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",20,TRUE,1,"Male",15,"mortality",0.0494611546825165,0.0511569934310889,0.0482606890284753
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",20,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",21,TRUE,1,"Male",5,"prevalence",5.923576734e-07,5.353559927e-07,6.535833343e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",21,TRUE,1,"Male",6,"incidence",1.747797262e-07,1.570389282e-07,1.915613877e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",21,TRUE,1,"Male",15,"mortality",0.0494611546825165,0.0511569934310889,0.0482606890284753
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",21,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",22,TRUE,1,"Male",5,"prevalence",5.923576734e-07,5.353559927e-07,6.535833343e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",22,TRUE,1,"Male",6,"incidence",1.747797262e-07,1.570389282e-07,1.915613877e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",22,TRUE,1,"Male",15,"mortality",0.0494611546825165,0.0511569934310889,0.0482606890284753
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",22,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",23,TRUE,1,"Male",5,"prevalence",5.923576734e-07,5.353559927e-07,6.535833343e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",23,TRUE,1,"Male",6,"incidence",1.747797262e-07,1.570389282e-07,1.915613877e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",23,TRUE,1,"Male",15,"mortality",0.0494611546825165,0.0511569934310889,0.0482606890284753
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",23,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",24,TRUE,1,"Male",5,"prevalence",5.923576734e-07,5.353559927e-07,6.535833343e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",24,TRUE,1,"Male",6,"incidence",1.747797262e-07,1.570389282e-07,1.915613877e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",24,TRUE,1,"Male",15,"mortality",0.0494611546825165,0.0511569934310889,0.0482606890284753
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",24,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",20,TRUE,2,"Female",5,"prevalence",5.291060333e-07,4.847630506e-07,5.801696465e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",20,TRUE,2,"Female",6,"incidence",1.952885272e-07,1.799550779e-07,2.139467101e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",20,TRUE,2,"Female",15,"mortality",0.0977033225192857,0.10281704624056,0.0932636436931988
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",20,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",21,TRUE,2,"Female",5,"prevalence",5.291060333e-07,4.847630506e-07,5.801696465e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",21,TRUE,2,"Female",6,"incidence",1.952885272e-07,1.799550779e-07,2.139467101e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",21,TRUE,2,"Female",15,"mortality",0.0977033225192857,0.10281704624056,0.0932636436931988
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",21,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",22,TRUE,2,"Female",5,"prevalence",5.291060333e-07,4.847630506e-07,5.801696465e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",22,TRUE,2,"Female",6,"incidence",1.952885272e-07,1.799550779e-07,2.139467101e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",22,TRUE,2,"Female",15,"mortality",0.0977033225192857,0.10281704624056,0.0932636436931988
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",22,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",23,TRUE,2,"Female",5,"prevalence",5.291060333e-07,4.847630506e-07,5.801696465e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",23,TRUE,2,"Female",6,"incidence",1.952885272e-07,1.799550779e-07,2.139467101e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",23,TRUE,2,"Female",15,"mortality",0.0977033225192857,0.10281704624056,0.0932636436931988
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",23,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",24,TRUE,2,"Female",5,"prevalence",5.291060333e-07,4.847630506e-07,5.801696465e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",24,TRUE,2,"Female",6,"incidence",1.952885272e-07,1.799550779e-07,2.139467101e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",24,TRUE,2,"Female",15,"mortality",0.0977033225192857,0.10281704624056,0.0932636436931988
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,9,"20-24 years",24,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",25,TRUE,1,"Male",5,"prevalence",2.3093667477e-06,2.1251257328e-06,2.5225591703e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",25,TRUE,1,"Male",6,"incidence",6.698488244e-07,6.173605663e-07,7.269525256e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",25,TRUE,1,"Male",15,"mortality",0.0449584617031917,0.0467251397985315,0.0429971277099583
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",25,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",26,TRUE,1,"Male",5,"prevalence",2.3093667477e-06,2.1251257328e-06,2.5225591703e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",26,TRUE,1,"Male",6,"incidence",6.698488244e-07,6.173605663e-07,7.269525256e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",26,TRUE,1,"Male",15,"mortality",0.0449584617031917,0.0467251397985315,0.0429971277099583
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",26,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",27,TRUE,1,"Male",5,"prevalence",2.3093667477e-06,2.1251257328e-06,2.5225591703e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",27,TRUE,1,"Male",6,"incidence",6.698488244e-07,6.173605663e-07,7.269525256e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",27,TRUE,1,"Male",15,"mortality",0.0449584617031917,0.0467251397985315,0.0429971277099583
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",27,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",28,TRUE,1,"Male",5,"prevalence",2.3093667477e-06,2.1251257328e-06,2.5225591703e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",28,TRUE,1,"Male",6,"incidence",6.698488244e-07,6.173605663e-07,7.269525256e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",28,TRUE,1,"Male",15,"mortality",0.0449584617031917,0.0467251397985315,0.0429971277099583
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",28,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",29,TRUE,1,"Male",5,"prevalence",2.3093667477e-06,2.1251257328e-06,2.5225591703e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",29,TRUE,1,"Male",6,"incidence",6.698488244e-07,6.173605663e-07,7.269525256e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",29,TRUE,1,"Male",15,"mortality",0.0449584617031917,0.0467251397985315,0.0429971277099583
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",29,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",25,TRUE,2,"Female",5,"prevalence",1.6562431606e-06,1.5239997296e-06,1.8070646556e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",25,TRUE,2,"Female",6,"incidence",5.957916814e-07,5.51058877e-07,6.45254814e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",25,TRUE,2,"Female",15,"mortality",0.0886392111364496,0.0924188705932273,0.0847447181266073
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",25,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",26,TRUE,2,"Female",5,"prevalence",1.6562431606e-06,1.5239997296e-06,1.8070646556e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",26,TRUE,2,"Female",6,"incidence",5.957916814e-07,5.51058877e-07,6.45254814e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",26,TRUE,2,"Female",15,"mortality",0.0886392111364496,0.0924188705932273,0.0847447181266073
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",26,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",27,TRUE,2,"Female",5,"prevalence",1.6562431606e-06,1.5239997296e-06,1.8070646556e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",27,TRUE,2,"Female",6,"incidence",5.957916814e-07,5.51058877e-07,6.45254814e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",27,TRUE,2,"Female",15,"mortality",0.0886392111364496,0.0924188705932273,0.0847447181266073
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",27,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",28,TRUE,2,"Female",5,"prevalence",1.6562431606e-06,1.5239997296e-06,1.8070646556e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",28,TRUE,2,"Female",6,"incidence",5.957916814e-07,5.51058877e-07,6.45254814e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",28,TRUE,2,"Female",15,"mortality",0.0886392111364496,0.0924188705932273,0.0847447181266073
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",28,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",29,TRUE,2,"Female",5,"prevalence",1.6562431606e-06,1.5239997296e-06,1.8070646556e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",29,TRUE,2,"Female",6,"incidence",5.957916814e-07,5.51058877e-07,6.45254814e-07
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",29,TRUE,2,"Female",15,"mortality",0.0886392111364496,0.0924188705932273,0.0847447181266073
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,10,"25-29 years",29,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",30,TRUE,1,"Male",5,"prevalence",9.2199469334e-06,8.5467316263e-06,9.8863162995e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",30,TRUE,1,"Male",6,"incidence",2.3830224906e-06,2.2105606484e-06,2.5504860435e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",30,TRUE,1,"Male",15,"mortality",0.0408391193940363,0.0420453181601617,0.0398723226126378
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",30,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",31,TRUE,1,"Male",5,"prevalence",9.2199469334e-06,8.5467316263e-06,9.8863162995e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",31,TRUE,1,"Male",6,"incidence",2.3830224906e-06,2.2105606484e-06,2.5504860435e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",31,TRUE,1,"Male",15,"mortality",0.0408391193940363,0.0420453181601617,0.0398723226126378
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",31,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",32,TRUE,1,"Male",5,"prevalence",9.2199469334e-06,8.5467316263e-06,9.8863162995e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",32,TRUE,1,"Male",6,"incidence",2.3830224906e-06,2.2105606484e-06,2.5504860435e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",32,TRUE,1,"Male",15,"mortality",0.0408391193940363,0.0420453181601617,0.0398723226126378
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",32,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",33,TRUE,1,"Male",5,"prevalence",9.2199469334e-06,8.5467316263e-06,9.8863162995e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",33,TRUE,1,"Male",6,"incidence",2.3830224906e-06,2.2105606484e-06,2.5504860435e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",33,TRUE,1,"Male",15,"mortality",0.0408391193940363,0.0420453181601617,0.0398723226126378
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",33,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",34,TRUE,1,"Male",5,"prevalence",9.2199469334e-06,8.5467316263e-06,9.8863162995e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",34,TRUE,1,"Male",6,"incidence",2.3830224906e-06,2.2105606484e-06,2.5504860435e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",34,TRUE,1,"Male",15,"mortality",0.0408391193940363,0.0420453181601617,0.0398723226126378
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",34,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",30,TRUE,2,"Female",5,"prevalence",4.5704317651e-06,4.1947033119e-06,4.961217087e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",30,TRUE,2,"Female",6,"incidence",1.5250451201e-06,1.3981903956e-06,1.6418611127e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",30,TRUE,2,"Female",15,"mortality",0.0809349670482961,0.0843228748227937,0.0774947803649197
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",30,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",31,TRUE,2,"Female",5,"prevalence",4.5704317651e-06,4.1947033119e-06,4.961217087e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",31,TRUE,2,"Female",6,"incidence",1.5250451201e-06,1.3981903956e-06,1.6418611127e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",31,TRUE,2,"Female",15,"mortality",0.0809349670482961,0.0843228748227937,0.0774947803649197
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",31,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",32,TRUE,2,"Female",5,"prevalence",4.5704317651e-06,4.1947033119e-06,4.961217087e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",32,TRUE,2,"Female",6,"incidence",1.5250451201e-06,1.3981903956e-06,1.6418611127e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",32,TRUE,2,"Female",15,"mortality",0.0809349670482961,0.0843228748227937,0.0774947803649197
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",32,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",33,TRUE,2,"Female",5,"prevalence",4.5704317651e-06,4.1947033119e-06,4.961217087e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",33,TRUE,2,"Female",6,"incidence",1.5250451201e-06,1.3981903956e-06,1.6418611127e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",33,TRUE,2,"Female",15,"mortality",0.0809349670482961,0.0843228748227937,0.0774947803649197
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",33,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",34,TRUE,2,"Female",5,"prevalence",4.5704317651e-06,4.1947033119e-06,4.961217087e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",34,TRUE,2,"Female",6,"incidence",1.5250451201e-06,1.3981903956e-06,1.6418611127e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",34,TRUE,2,"Female",15,"mortality",0.0809349670482961,0.0843228748227937,0.0774947803649197
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,11,"30-34 years",34,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",35,TRUE,1,"Male",5,"prevalence",1.51810339097e-05,1.42473522692e-05,1.60731058325e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",35,TRUE,1,"Male",6,"incidence",4.8961499179e-06,4.5954927556e-06,5.1847809159e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",35,TRUE,1,"Male",15,"mortality",0.0544495848212809,0.0547752641166662,0.0543217628094322
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",35,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",36,TRUE,1,"Male",5,"prevalence",1.51810339097e-05,1.42473522692e-05,1.60731058325e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",36,TRUE,1,"Male",6,"incidence",4.8961499179e-06,4.5954927556e-06,5.1847809159e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",36,TRUE,1,"Male",15,"mortality",0.0544495848212809,0.0547752641166662,0.0543217628094322
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",36,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",37,TRUE,1,"Male",5,"prevalence",1.51810339097e-05,1.42473522692e-05,1.60731058325e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",37,TRUE,1,"Male",6,"incidence",4.8961499179e-06,4.5954927556e-06,5.1847809159e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",37,TRUE,1,"Male",15,"mortality",0.0544495848212809,0.0547752641166662,0.0543217628094322
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",37,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",38,TRUE,1,"Male",5,"prevalence",1.51810339097e-05,1.42473522692e-05,1.60731058325e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",38,TRUE,1,"Male",6,"incidence",4.8961499179e-06,4.5954927556e-06,5.1847809159e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",38,TRUE,1,"Male",15,"mortality",0.0544495848212809,0.0547752641166662,0.0543217628094322
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",38,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",39,TRUE,1,"Male",5,"prevalence",1.51810339097e-05,1.42473522692e-05,1.60731058325e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",39,TRUE,1,"Male",6,"incidence",4.8961499179e-06,4.5954927556e-06,5.1847809159e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",39,TRUE,1,"Male",15,"mortality",0.0544495848212809,0.0547752641166662,0.0543217628094322
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",39,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",35,TRUE,2,"Female",5,"prevalence",1.25366613671e-05,1.14145264482e-05,1.36026046287e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",35,TRUE,2,"Female",6,"incidence",4.0842697855e-06,3.7380073668e-06,4.4070264296e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",35,TRUE,2,"Female",15,"mortality",0.075693627974942,0.078636456766704,0.0735969514012667
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",35,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",36,TRUE,2,"Female",5,"prevalence",1.25366613671e-05,1.14145264482e-05,1.36026046287e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",36,TRUE,2,"Female",6,"incidence",4.0842697855e-06,3.7380073668e-06,4.4070264296e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",36,TRUE,2,"Female",15,"mortality",0.075693627974942,0.078636456766704,0.0735969514012667
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",36,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",37,TRUE,2,"Female",5,"prevalence",1.25366613671e-05,1.14145264482e-05,1.36026046287e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",37,TRUE,2,"Female",6,"incidence",4.0842697855e-06,3.7380073668e-06,4.4070264296e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",37,TRUE,2,"Female",15,"mortality",0.075693627974942,0.078636456766704,0.0735969514012667
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",37,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",38,TRUE,2,"Female",5,"prevalence",1.25366613671e-05,1.14145264482e-05,1.36026046287e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",38,TRUE,2,"Female",6,"incidence",4.0842697855e-06,3.7380073668e-06,4.4070264296e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",38,TRUE,2,"Female",15,"mortality",0.075693627974942,0.078636456766704,0.0735969514012667
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",38,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",39,TRUE,2,"Female",5,"prevalence",1.25366613671e-05,1.14145264482e-05,1.36026046287e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",39,TRUE,2,"Female",6,"incidence",4.0842697855e-06,3.7380073668e-06,4.4070264296e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",39,TRUE,2,"Female",15,"mortality",0.075693627974942,0.078636456766704,0.0735969514012667
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,12,"35-39 years",39,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",40,TRUE,1,"Male",5,"prevalence",3.10747598101e-05,2.91996085676e-05,3.28403187017e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",40,TRUE,1,"Male",6,"incidence",8.9266351571e-06,8.4091397334e-06,9.4446372389e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",40,TRUE,1,"Male",15,"mortality",0.0529001440065565,0.0531636171908824,0.0527049467796526
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",40,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",41,TRUE,1,"Male",5,"prevalence",3.10747598101e-05,2.91996085676e-05,3.28403187017e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",41,TRUE,1,"Male",6,"incidence",8.9266351571e-06,8.4091397334e-06,9.4446372389e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",41,TRUE,1,"Male",15,"mortality",0.0529001440065565,0.0531636171908824,0.0527049467796526
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",41,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",42,TRUE,1,"Male",5,"prevalence",3.10747598101e-05,2.91996085676e-05,3.28403187017e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",42,TRUE,1,"Male",6,"incidence",8.9266351571e-06,8.4091397334e-06,9.4446372389e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",42,TRUE,1,"Male",15,"mortality",0.0529001440065565,0.0531636171908824,0.0527049467796526
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",42,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",43,TRUE,1,"Male",5,"prevalence",3.10747598101e-05,2.91996085676e-05,3.28403187017e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",43,TRUE,1,"Male",6,"incidence",8.9266351571e-06,8.4091397334e-06,9.4446372389e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",43,TRUE,1,"Male",15,"mortality",0.0529001440065565,0.0531636171908824,0.0527049467796526
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",43,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",44,TRUE,1,"Male",5,"prevalence",3.10747598101e-05,2.91996085676e-05,3.28403187017e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",44,TRUE,1,"Male",6,"incidence",8.9266351571e-06,8.4091397334e-06,9.4446372389e-06
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",44,TRUE,1,"Male",15,"mortality",0.0529001440065565,0.0531636171908824,0.0527049467796526
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",44,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",40,TRUE,2,"Female",5,"prevalence",3.0357257945e-05,2.80256551049e-05,3.2797414082e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",40,TRUE,2,"Female",6,"incidence",9.9699826423e-06,9.2038501897e-06,1.07672452406e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",40,TRUE,2,"Female",15,"mortality",0.079732913561441,0.0828553797271791,0.0768291874991496
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",40,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",41,TRUE,2,"Female",5,"prevalence",3.0357257945e-05,2.80256551049e-05,3.2797414082e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",41,TRUE,2,"Female",6,"incidence",9.9699826423e-06,9.2038501897e-06,1.07672452406e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",41,TRUE,2,"Female",15,"mortality",0.079732913561441,0.0828553797271791,0.0768291874991496
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",41,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",42,TRUE,2,"Female",5,"prevalence",3.0357257945e-05,2.80256551049e-05,3.2797414082e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",42,TRUE,2,"Female",6,"incidence",9.9699826423e-06,9.2038501897e-06,1.07672452406e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",42,TRUE,2,"Female",15,"mortality",0.079732913561441,0.0828553797271791,0.0768291874991496
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",42,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",43,TRUE,2,"Female",5,"prevalence",3.0357257945e-05,2.80256551049e-05,3.2797414082e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",43,TRUE,2,"Female",6,"incidence",9.9699826423e-06,9.2038501897e-06,1.07672452406e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",43,TRUE,2,"Female",15,"mortality",0.079732913561441,0.0828553797271791,0.0768291874991496
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",43,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",44,TRUE,2,"Female",5,"prevalence",3.0357257945e-05,2.80256551049e-05,3.2797414082e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",44,TRUE,2,"Female",6,"incidence",9.9699826423e-06,9.2038501897e-06,1.07672452406e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",44,TRUE,2,"Female",15,"mortality",0.079732913561441,0.0828553797271791,0.0768291874991496
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,13,"40-44 years",44,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",45,TRUE,1,"Male",5,"prevalence",4.37893353865e-05,4.11274827652e-05,4.62186656261e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",45,TRUE,1,"Male",6,"incidence",1.53645148004e-05,1.44767105091e-05,1.62337937854e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",45,TRUE,1,"Male",15,"mortality",0.080537760896371,0.0817264072772021,0.0798883813118174
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",45,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",46,TRUE,1,"Male",5,"prevalence",4.37893353865e-05,4.11274827652e-05,4.62186656261e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",46,TRUE,1,"Male",6,"incidence",1.53645148004e-05,1.44767105091e-05,1.62337937854e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",46,TRUE,1,"Male",15,"mortality",0.080537760896371,0.0817264072772021,0.0798883813118174
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",46,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",47,TRUE,1,"Male",5,"prevalence",4.37893353865e-05,4.11274827652e-05,4.62186656261e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",47,TRUE,1,"Male",6,"incidence",1.53645148004e-05,1.44767105091e-05,1.62337937854e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",47,TRUE,1,"Male",15,"mortality",0.080537760896371,0.0817264072772021,0.0798883813118174
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",47,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",48,TRUE,1,"Male",5,"prevalence",4.37893353865e-05,4.11274827652e-05,4.62186656261e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",48,TRUE,1,"Male",6,"incidence",1.53645148004e-05,1.44767105091e-05,1.62337937854e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",48,TRUE,1,"Male",15,"mortality",0.080537760896371,0.0817264072772021,0.0798883813118174
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",48,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",49,TRUE,1,"Male",5,"prevalence",4.37893353865e-05,4.11274827652e-05,4.62186656261e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",49,TRUE,1,"Male",6,"incidence",1.53645148004e-05,1.44767105091e-05,1.62337937854e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",49,TRUE,1,"Male",15,"mortality",0.080537760896371,0.0817264072772021,0.0798883813118174
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",49,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",45,TRUE,2,"Female",5,"prevalence",4.92822979807e-05,4.52444113491e-05,5.30898120385e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",45,TRUE,2,"Female",6,"incidence",1.61623445268e-05,1.49574375353e-05,1.72873654533e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",45,TRUE,2,"Female",15,"mortality",0.105622288212837,0.110857290227792,0.101370423491631
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",45,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",46,TRUE,2,"Female",5,"prevalence",4.92822979807e-05,4.52444113491e-05,5.30898120385e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",46,TRUE,2,"Female",6,"incidence",1.61623445268e-05,1.49574375353e-05,1.72873654533e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",46,TRUE,2,"Female",15,"mortality",0.105622288212837,0.110857290227792,0.101370423491631
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",46,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",47,TRUE,2,"Female",5,"prevalence",4.92822979807e-05,4.52444113491e-05,5.30898120385e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",47,TRUE,2,"Female",6,"incidence",1.61623445268e-05,1.49574375353e-05,1.72873654533e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",47,TRUE,2,"Female",15,"mortality",0.105622288212837,0.110857290227792,0.101370423491631
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",47,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",48,TRUE,2,"Female",5,"prevalence",4.92822979807e-05,4.52444113491e-05,5.30898120385e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",48,TRUE,2,"Female",6,"incidence",1.61623445268e-05,1.49574375353e-05,1.72873654533e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",48,TRUE,2,"Female",15,"mortality",0.105622288212837,0.110857290227792,0.101370423491631
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",48,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",49,TRUE,2,"Female",5,"prevalence",4.92822979807e-05,4.52444113491e-05,5.30898120385e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",49,TRUE,2,"Female",6,"incidence",1.61623445268e-05,1.49574375353e-05,1.72873654533e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",49,TRUE,2,"Female",15,"mortality",0.105622288212837,0.110857290227792,0.101370423491631
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,14,"45-49 years",49,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",50,TRUE,1,"Male",5,"prevalence",7.61692405684e-05,7.1275670509e-05,8.10944685135e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",50,TRUE,1,"Male",6,"incidence",2.49665751319e-05,2.33801050955e-05,2.66204934101e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",50,TRUE,1,"Male",15,"mortality",0.0895632486932383,0.091826765891105,0.0873024354624605
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",50,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",51,TRUE,1,"Male",5,"prevalence",7.61692405684e-05,7.1275670509e-05,8.10944685135e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",51,TRUE,1,"Male",6,"incidence",2.49665751319e-05,2.33801050955e-05,2.66204934101e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",51,TRUE,1,"Male",15,"mortality",0.0895632486932383,0.091826765891105,0.0873024354624605
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",51,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",52,TRUE,1,"Male",5,"prevalence",7.61692405684e-05,7.1275670509e-05,8.10944685135e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",52,TRUE,1,"Male",6,"incidence",2.49665751319e-05,2.33801050955e-05,2.66204934101e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",52,TRUE,1,"Male",15,"mortality",0.0895632486932383,0.091826765891105,0.0873024354624605
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",52,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",53,TRUE,1,"Male",5,"prevalence",7.61692405684e-05,7.1275670509e-05,8.10944685135e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",53,TRUE,1,"Male",6,"incidence",2.49665751319e-05,2.33801050955e-05,2.66204934101e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",53,TRUE,1,"Male",15,"mortality",0.0895632486932383,0.091826765891105,0.0873024354624605
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",53,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",54,TRUE,1,"Male",5,"prevalence",7.61692405684e-05,7.1275670509e-05,8.10944685135e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",54,TRUE,1,"Male",6,"incidence",2.49665751319e-05,2.33801050955e-05,2.66204934101e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",54,TRUE,1,"Male",15,"mortality",0.0895632486932383,0.091826765891105,0.0873024354624605
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",54,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",50,TRUE,2,"Female",5,"prevalence",7.11638588154e-05,6.64909153369e-05,7.66603851872e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",50,TRUE,2,"Female",6,"incidence",2.58952542748e-05,2.42561331841e-05,2.7647101123e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",50,TRUE,2,"Female",15,"mortality",0.14199906927867,0.146718871378582,0.137047996621865
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",50,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",51,TRUE,2,"Female",5,"prevalence",7.11638588154e-05,6.64909153369e-05,7.66603851872e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",51,TRUE,2,"Female",6,"incidence",2.58952542748e-05,2.42561331841e-05,2.7647101123e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",51,TRUE,2,"Female",15,"mortality",0.14199906927867,0.146718871378582,0.137047996621865
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",51,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",52,TRUE,2,"Female",5,"prevalence",7.11638588154e-05,6.64909153369e-05,7.66603851872e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",52,TRUE,2,"Female",6,"incidence",2.58952542748e-05,2.42561331841e-05,2.7647101123e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",52,TRUE,2,"Female",15,"mortality",0.14199906927867,0.146718871378582,0.137047996621865
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",52,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",53,TRUE,2,"Female",5,"prevalence",7.11638588154e-05,6.64909153369e-05,7.66603851872e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",53,TRUE,2,"Female",6,"incidence",2.58952542748e-05,2.42561331841e-05,2.7647101123e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",53,TRUE,2,"Female",15,"mortality",0.14199906927867,0.146718871378582,0.137047996621865
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",53,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",54,TRUE,2,"Female",5,"prevalence",7.11638588154e-05,6.64909153369e-05,7.66603851872e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",54,TRUE,2,"Female",6,"incidence",2.58952542748e-05,2.42561331841e-05,2.7647101123e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",54,TRUE,2,"Female",15,"mortality",0.14199906927867,0.146718871378582,0.137047996621865
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,15,"50-54 years",54,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",55,TRUE,1,"Male",5,"prevalence",0.0001350820536318,0.0001267032458851,0.0001425493060944
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",55,TRUE,1,"Male",6,"incidence",4.16530256435e-05,3.92398346606e-05,4.36909179806e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",55,TRUE,1,"Male",15,"mortality",0.0851814342221643,0.0871487492268475,0.0838434706547476
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",55,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",56,TRUE,1,"Male",5,"prevalence",0.0001350820536318,0.0001267032458851,0.0001425493060944
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",56,TRUE,1,"Male",6,"incidence",4.16530256435e-05,3.92398346606e-05,4.36909179806e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",56,TRUE,1,"Male",15,"mortality",0.0851814342221643,0.0871487492268475,0.0838434706547476
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",56,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",57,TRUE,1,"Male",5,"prevalence",0.0001350820536318,0.0001267032458851,0.0001425493060944
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",57,TRUE,1,"Male",6,"incidence",4.16530256435e-05,3.92398346606e-05,4.36909179806e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",57,TRUE,1,"Male",15,"mortality",0.0851814342221643,0.0871487492268475,0.0838434706547476
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",57,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",58,TRUE,1,"Male",5,"prevalence",0.0001350820536318,0.0001267032458851,0.0001425493060944
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",58,TRUE,1,"Male",6,"incidence",4.16530256435e-05,3.92398346606e-05,4.36909179806e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",58,TRUE,1,"Male",15,"mortality",0.0851814342221643,0.0871487492268475,0.0838434706547476
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",58,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",59,TRUE,1,"Male",5,"prevalence",0.0001350820536318,0.0001267032458851,0.0001425493060944
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",59,TRUE,1,"Male",6,"incidence",4.16530256435e-05,3.92398346606e-05,4.36909179806e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",59,TRUE,1,"Male",15,"mortality",0.0851814342221643,0.0871487492268475,0.0838434706547476
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",59,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",55,TRUE,2,"Female",5,"prevalence",0.0001123385916104,0.0001042346690602,0.0001218037958711
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",55,TRUE,2,"Female",6,"incidence",4.47039731597e-05,4.18571665537e-05,4.77662836366e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",55,TRUE,2,"Female",15,"mortality",0.156334852957594,0.161578317816121,0.149729953566912
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",55,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",56,TRUE,2,"Female",5,"prevalence",0.0001123385916104,0.0001042346690602,0.0001218037958711
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",56,TRUE,2,"Female",6,"incidence",4.47039731597e-05,4.18571665537e-05,4.77662836366e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",56,TRUE,2,"Female",15,"mortality",0.156334852957594,0.161578317816121,0.149729953566912
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",56,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",57,TRUE,2,"Female",5,"prevalence",0.0001123385916104,0.0001042346690602,0.0001218037958711
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",57,TRUE,2,"Female",6,"incidence",4.47039731597e-05,4.18571665537e-05,4.77662836366e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",57,TRUE,2,"Female",15,"mortality",0.156334852957594,0.161578317816121,0.149729953566912
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",57,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",58,TRUE,2,"Female",5,"prevalence",0.0001123385916104,0.0001042346690602,0.0001218037958711
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",58,TRUE,2,"Female",6,"incidence",4.47039731597e-05,4.18571665537e-05,4.77662836366e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",58,TRUE,2,"Female",15,"mortality",0.156334852957594,0.161578317816121,0.149729953566912
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",58,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",59,TRUE,2,"Female",5,"prevalence",0.0001123385916104,0.0001042346690602,0.0001218037958711
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",59,TRUE,2,"Female",6,"incidence",4.47039731597e-05,4.18571665537e-05,4.77662836366e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",59,TRUE,2,"Female",15,"mortality",0.156334852957594,0.161578317816121,0.149729953566912
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,16,"55-59 years",59,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",60,TRUE,1,"Male",5,"prevalence",0.0001755917152805,0.0001635835929526,0.0001871887731848
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",60,TRUE,1,"Male",6,"incidence",5.94137198434e-05,5.56801675187e-05,6.32794541213e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",60,TRUE,1,"Male",15,"mortality",0.105950644594574,0.109128540004161,0.10362862102764
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",60,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",61,TRUE,1,"Male",5,"prevalence",0.0001755917152805,0.0001635835929526,0.0001871887731848
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",61,TRUE,1,"Male",6,"incidence",5.94137198434e-05,5.56801675187e-05,6.32794541213e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",61,TRUE,1,"Male",15,"mortality",0.105950644594574,0.109128540004161,0.10362862102764
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",61,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",62,TRUE,1,"Male",5,"prevalence",0.0001755917152805,0.0001635835929526,0.0001871887731848
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",62,TRUE,1,"Male",6,"incidence",5.94137198434e-05,5.56801675187e-05,6.32794541213e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",62,TRUE,1,"Male",15,"mortality",0.105950644594574,0.109128540004161,0.10362862102764
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",62,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",63,TRUE,1,"Male",5,"prevalence",0.0001755917152805,0.0001635835929526,0.0001871887731848
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",63,TRUE,1,"Male",6,"incidence",5.94137198434e-05,5.56801675187e-05,6.32794541213e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",63,TRUE,1,"Male",15,"mortality",0.105950644594574,0.109128540004161,0.10362862102764
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",63,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",64,TRUE,1,"Male",5,"prevalence",0.0001755917152805,0.0001635835929526,0.0001871887731848
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",64,TRUE,1,"Male",6,"incidence",5.94137198434e-05,5.56801675187e-05,6.32794541213e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",64,TRUE,1,"Male",15,"mortality",0.105950644594574,0.109128540004161,0.10362862102764
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",64,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",60,TRUE,2,"Female",5,"prevalence",0.0001460594731756,0.0001347498205875,0.000158843230041
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",60,TRUE,2,"Female",6,"incidence",6.31587580096e-05,5.84331310668e-05,6.80710512516e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",60,TRUE,2,"Female",15,"mortality",0.192987450450088,0.198153835371291,0.185497550904554
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",60,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",61,TRUE,2,"Female",5,"prevalence",0.0001460594731756,0.0001347498205875,0.000158843230041
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",61,TRUE,2,"Female",6,"incidence",6.31587580096e-05,5.84331310668e-05,6.80710512516e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",61,TRUE,2,"Female",15,"mortality",0.192987450450088,0.198153835371291,0.185497550904554
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",61,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",62,TRUE,2,"Female",5,"prevalence",0.0001460594731756,0.0001347498205875,0.000158843230041
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",62,TRUE,2,"Female",6,"incidence",6.31587580096e-05,5.84331310668e-05,6.80710512516e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",62,TRUE,2,"Female",15,"mortality",0.192987450450088,0.198153835371291,0.185497550904554
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",62,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",63,TRUE,2,"Female",5,"prevalence",0.0001460594731756,0.0001347498205875,0.000158843230041
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",63,TRUE,2,"Female",6,"incidence",6.31587580096e-05,5.84331310668e-05,6.80710512516e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",63,TRUE,2,"Female",15,"mortality",0.192987450450088,0.198153835371291,0.185497550904554
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",63,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",64,TRUE,2,"Female",5,"prevalence",0.0001460594731756,0.0001347498205875,0.000158843230041
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",64,TRUE,2,"Female",6,"incidence",6.31587580096e-05,5.84331310668e-05,6.80710512516e-05
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",64,TRUE,2,"Female",15,"mortality",0.192987450450088,0.198153835371291,0.185497550904554
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,17,"60-64 years",64,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",65,TRUE,1,"Male",5,"prevalence",0.0003046657901525,0.0002825206261713,0.0003267979948555
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",65,TRUE,1,"Male",6,"incidence",0.0001034817225549,9.63288628192e-05,0.0001106041754914
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",65,TRUE,1,"Male",15,"mortality",0.0992940980108754,0.1023522839246,0.0962667408199787
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",65,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",66,TRUE,1,"Male",5,"prevalence",0.0003046657901525,0.0002825206261713,0.0003267979948555
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",66,TRUE,1,"Male",6,"incidence",0.0001034817225549,9.63288628192e-05,0.0001106041754914
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",66,TRUE,1,"Male",15,"mortality",0.0992940980108754,0.1023522839246,0.0962667408199787
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",66,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",67,TRUE,1,"Male",5,"prevalence",0.0003046657901525,0.0002825206261713,0.0003267979948555
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",67,TRUE,1,"Male",6,"incidence",0.0001034817225549,9.63288628192e-05,0.0001106041754914
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",67,TRUE,1,"Male",15,"mortality",0.0992940980108754,0.1023522839246,0.0962667408199787
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",67,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",68,TRUE,1,"Male",5,"prevalence",0.0003046657901525,0.0002825206261713,0.0003267979948555
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",68,TRUE,1,"Male",6,"incidence",0.0001034817225549,9.63288628192e-05,0.0001106041754914
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",68,TRUE,1,"Male",15,"mortality",0.0992940980108754,0.1023522839246,0.0962667408199787
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",68,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",69,TRUE,1,"Male",5,"prevalence",0.0003046657901525,0.0002825206261713,0.0003267979948555
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",69,TRUE,1,"Male",6,"incidence",0.0001034817225549,9.63288628192e-05,0.0001106041754914
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",69,TRUE,1,"Male",15,"mortality",0.0992940980108754,0.1023522839246,0.0962667408199787
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",69,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",65,TRUE,2,"Female",5,"prevalence",0.0002246084915783,0.0002037993302373,0.0002437657942038
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",65,TRUE,2,"Female",6,"incidence",9.85608705348e-05,9.044003826e-05,0.000106271115211
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",65,TRUE,2,"Female",15,"mortality",0.18986576708039,0.195392179874942,0.183157821682896
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",65,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",66,TRUE,2,"Female",5,"prevalence",0.0002246084915783,0.0002037993302373,0.0002437657942038
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",66,TRUE,2,"Female",6,"incidence",9.85608705348e-05,9.044003826e-05,0.000106271115211
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",66,TRUE,2,"Female",15,"mortality",0.18986576708039,0.195392179874942,0.183157821682896
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",66,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",67,TRUE,2,"Female",5,"prevalence",0.0002246084915783,0.0002037993302373,0.0002437657942038
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",67,TRUE,2,"Female",6,"incidence",9.85608705348e-05,9.044003826e-05,0.000106271115211
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",67,TRUE,2,"Female",15,"mortality",0.18986576708039,0.195392179874942,0.183157821682896
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",67,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",68,TRUE,2,"Female",5,"prevalence",0.0002246084915783,0.0002037993302373,0.0002437657942038
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",68,TRUE,2,"Female",6,"incidence",9.85608705348e-05,9.044003826e-05,0.000106271115211
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",68,TRUE,2,"Female",15,"mortality",0.18986576708039,0.195392179874942,0.183157821682896
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",68,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",69,TRUE,2,"Female",5,"prevalence",0.0002246084915783,0.0002037993302373,0.0002437657942038
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",69,TRUE,2,"Female",6,"incidence",9.85608705348e-05,9.044003826e-05,0.000106271115211
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",69,TRUE,2,"Female",15,"mortality",0.18986576708039,0.195392179874942,0.183157821682896
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,18,"65-69 years",69,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",70,TRUE,1,"Male",5,"prevalence",0.0004032079029117,0.0003723789346117,0.0004332089846363
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",70,TRUE,1,"Male",6,"incidence",0.0001498134377367,0.000138949431432,0.0001602573933008
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",70,TRUE,1,"Male",15,"mortality",0.11754330395052,0.120814727894482,0.114134462920127
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",70,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",71,TRUE,1,"Male",5,"prevalence",0.0004032079029117,0.0003723789346117,0.0004332089846363
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",71,TRUE,1,"Male",6,"incidence",0.0001498134377367,0.000138949431432,0.0001602573933008
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",71,TRUE,1,"Male",15,"mortality",0.11754330395052,0.120814727894482,0.114134462920127
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",71,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",72,TRUE,1,"Male",5,"prevalence",0.0004032079029117,0.0003723789346117,0.0004332089846363
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",72,TRUE,1,"Male",6,"incidence",0.0001498134377367,0.000138949431432,0.0001602573933008
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",72,TRUE,1,"Male",15,"mortality",0.11754330395052,0.120814727894482,0.114134462920127
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",72,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",73,TRUE,1,"Male",5,"prevalence",0.0004032079029117,0.0003723789346117,0.0004332089846363
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",73,TRUE,1,"Male",6,"incidence",0.0001498134377367,0.000138949431432,0.0001602573933008
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",73,TRUE,1,"Male",15,"mortality",0.11754330395052,0.120814727894482,0.114134462920127
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",73,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",74,TRUE,1,"Male",5,"prevalence",0.0004032079029117,0.0003723789346117,0.0004332089846363
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",74,TRUE,1,"Male",6,"incidence",0.0001498134377367,0.000138949431432,0.0001602573933008
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",74,TRUE,1,"Male",15,"mortality",0.11754330395052,0.120814727894482,0.114134462920127
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",74,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",70,TRUE,2,"Female",5,"prevalence",0.000311974323836,0.0002780683472262,0.0003378382678716
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",70,TRUE,2,"Female",6,"incidence",0.0001429004585205,0.000129338434223,0.0001531728322778
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",70,TRUE,2,"Female",15,"mortality",0.218047575115264,0.224937212222722,0.211933914375031
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",70,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",71,TRUE,2,"Female",5,"prevalence",0.000311974323836,0.0002780683472262,0.0003378382678716
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",71,TRUE,2,"Female",6,"incidence",0.0001429004585205,0.000129338434223,0.0001531728322778
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",71,TRUE,2,"Female",15,"mortality",0.218047575115264,0.224937212222722,0.211933914375031
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",71,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",72,TRUE,2,"Female",5,"prevalence",0.000311974323836,0.0002780683472262,0.0003378382678716
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",72,TRUE,2,"Female",6,"incidence",0.0001429004585205,0.000129338434223,0.0001531728322778
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",72,TRUE,2,"Female",15,"mortality",0.218047575115264,0.224937212222722,0.211933914375031
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",72,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",73,TRUE,2,"Female",5,"prevalence",0.000311974323836,0.0002780683472262,0.0003378382678716
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",73,TRUE,2,"Female",6,"incidence",0.0001429004585205,0.000129338434223,0.0001531728322778
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",73,TRUE,2,"Female",15,"mortality",0.218047575115264,0.224937212222722,0.211933914375031
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",73,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",74,TRUE,2,"Female",5,"prevalence",0.000311974323836,0.0002780683472262,0.0003378382678716
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",74,TRUE,2,"Female",6,"incidence",0.0001429004585205,0.000129338434223,0.0001531728322778
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",74,TRUE,2,"Female",15,"mortality",0.218047575115264,0.224937212222722,0.211933914375031
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,19,"70-74 years",74,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",75,TRUE,1,"Male",5,"prevalence",0.0006159096410836,0.0005607068779503,0.0006677289396611
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",75,TRUE,1,"Male",6,"incidence",0.0002280267272631,0.0002066768220244,0.0002468965218381
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",75,TRUE,1,"Male",15,"mortality",0.125971834258673,0.129440396925364,0.121778507583288
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",75,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",76,TRUE,1,"Male",5,"prevalence",0.0006159096410836,0.0005607068779503,0.0006677289396611
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",76,TRUE,1,"Male",6,"incidence",0.0002280267272631,0.0002066768220244,0.0002468965218381
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",76,TRUE,1,"Male",15,"mortality",0.125971834258673,0.129440396925364,0.121778507583288
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",76,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",77,TRUE,1,"Male",5,"prevalence",0.0006159096410836,0.0005607068779503,0.0006677289396611
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",77,TRUE,1,"Male",6,"incidence",0.0002280267272631,0.0002066768220244,0.0002468965218381
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",77,TRUE,1,"Male",15,"mortality",0.125971834258673,0.129440396925364,0.121778507583288
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",77,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",78,TRUE,1,"Male",5,"prevalence",0.0006159096410836,0.0005607068779503,0.0006677289396611
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",78,TRUE,1,"Male",6,"incidence",0.0002280267272631,0.0002066768220244,0.0002468965218381
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",78,TRUE,1,"Male",15,"mortality",0.125971834258673,0.129440396925364,0.121778507583288
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",78,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",79,TRUE,1,"Male",5,"prevalence",0.0006159096410836,0.0005607068779503,0.0006677289396611
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",79,TRUE,1,"Male",6,"incidence",0.0002280267272631,0.0002066768220244,0.0002468965218381
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",79,TRUE,1,"Male",15,"mortality",0.125971834258673,0.129440396925364,0.121778507583288
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",79,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",75,TRUE,2,"Female",5,"prevalence",0.0004478516717472,0.0003920707391197,0.0004882290389456
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",75,TRUE,2,"Female",6,"incidence",0.0002225067862495,0.0001965389893582,0.0002406972611237
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",75,TRUE,2,"Female",15,"mortality",0.25153636076051,0.2585978824708,0.245206449477049
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",75,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",76,TRUE,2,"Female",5,"prevalence",0.0004478516717472,0.0003920707391197,0.0004882290389456
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",76,TRUE,2,"Female",6,"incidence",0.0002225067862495,0.0001965389893582,0.0002406972611237
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",76,TRUE,2,"Female",15,"mortality",0.25153636076051,0.2585978824708,0.245206449477049
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",76,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",77,TRUE,2,"Female",5,"prevalence",0.0004478516717472,0.0003920707391197,0.0004882290389456
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",77,TRUE,2,"Female",6,"incidence",0.0002225067862495,0.0001965389893582,0.0002406972611237
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",77,TRUE,2,"Female",15,"mortality",0.25153636076051,0.2585978824708,0.245206449477049
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",77,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",78,TRUE,2,"Female",5,"prevalence",0.0004478516717472,0.0003920707391197,0.0004882290389456
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",78,TRUE,2,"Female",6,"incidence",0.0002225067862495,0.0001965389893582,0.0002406972611237
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",78,TRUE,2,"Female",15,"mortality",0.25153636076051,0.2585978824708,0.245206449477049
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",78,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",79,TRUE,2,"Female",5,"prevalence",0.0004478516717472,0.0003920707391197,0.0004882290389456
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",79,TRUE,2,"Female",6,"incidence",0.0002225067862495,0.0001965389893582,0.0002406972611237
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",79,TRUE,2,"Female",15,"mortality",0.25153636076051,0.2585978824708,0.245206449477049
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,20,"75-79 years",79,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",80,TRUE,1,"Male",5,"prevalence",0.0008069190542367,0.0007138271190234,0.0008656502265581
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",80,TRUE,1,"Male",6,"incidence",0.0003032892499945,0.0002697011880437,0.0003245865520043
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",80,TRUE,1,"Male",15,"mortality",0.140135172831854,0.141935939096579,0.138757118549702
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",80,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",81,TRUE,1,"Male",5,"prevalence",0.0008069190542367,0.0007138271190234,0.0008656502265581
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",81,TRUE,1,"Male",6,"incidence",0.0003032892499945,0.0002697011880437,0.0003245865520043
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",81,TRUE,1,"Male",15,"mortality",0.140135172831854,0.141935939096579,0.138757118549702
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",81,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",82,TRUE,1,"Male",5,"prevalence",0.0008069190542367,0.0007138271190234,0.0008656502265581
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",82,TRUE,1,"Male",6,"incidence",0.0003032892499945,0.0002697011880437,0.0003245865520043
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",82,TRUE,1,"Male",15,"mortality",0.140135172831854,0.141935939096579,0.138757118549702
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",82,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",83,TRUE,1,"Male",5,"prevalence",0.0008069190542367,0.0007138271190234,0.0008656502265581
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",83,TRUE,1,"Male",6,"incidence",0.0003032892499945,0.0002697011880437,0.0003245865520043
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",83,TRUE,1,"Male",15,"mortality",0.140135172831854,0.141935939096579,0.138757118549702
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",83,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",84,TRUE,1,"Male",5,"prevalence",0.0008069190542367,0.0007138271190234,0.0008656502265581
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",84,TRUE,1,"Male",6,"incidence",0.0003032892499945,0.0002697011880437,0.0003245865520043
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",84,TRUE,1,"Male",15,"mortality",0.140135172831854,0.141935939096579,0.138757118549702
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",84,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",80,TRUE,2,"Female",5,"prevalence",0.0006703364505072,0.0005452362251372,0.0007479959640404
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",80,TRUE,2,"Female",6,"incidence",0.0003441565646466,0.0002804879280735,0.0003815828441805
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",80,TRUE,2,"Female",15,"mortality",0.267289001372422,0.271285505954767,0.261254017217755
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",80,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",81,TRUE,2,"Female",5,"prevalence",0.0006703364505072,0.0005452362251372,0.0007479959640404
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",81,TRUE,2,"Female",6,"incidence",0.0003441565646466,0.0002804879280735,0.0003815828441805
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",81,TRUE,2,"Female",15,"mortality",0.267289001372422,0.271285505954767,0.261254017217755
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",81,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",82,TRUE,2,"Female",5,"prevalence",0.0006703364505072,0.0005452362251372,0.0007479959640404
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",82,TRUE,2,"Female",6,"incidence",0.0003441565646466,0.0002804879280735,0.0003815828441805
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",82,TRUE,2,"Female",15,"mortality",0.267289001372422,0.271285505954767,0.261254017217755
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",82,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",83,TRUE,2,"Female",5,"prevalence",0.0006703364505072,0.0005452362251372,0.0007479959640404
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",83,TRUE,2,"Female",6,"incidence",0.0003441565646466,0.0002804879280735,0.0003815828441805
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",83,TRUE,2,"Female",15,"mortality",0.267289001372422,0.271285505954767,0.261254017217755
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",83,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",84,TRUE,2,"Female",5,"prevalence",0.0006703364505072,0.0005452362251372,0.0007479959640404
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",84,TRUE,2,"Female",6,"incidence",0.0003441565646466,0.0002804879280735,0.0003815828441805
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",84,TRUE,2,"Female",15,"mortality",0.267289001372422,0.271285505954767,0.261254017217755
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,30,"80-84 years",84,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",85,TRUE,1,"Male",5,"prevalence",0.0010299366646202,0.0008826261775512,0.0011409562972179
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",85,TRUE,1,"Male",6,"incidence",0.0004470744013172,0.000383122702421,0.0004929770860318
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",85,TRUE,1,"Male",15,"mortality",0.175329747659481,0.177837255074613,0.169198296163004
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",85,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",86,TRUE,1,"Male",5,"prevalence",0.0010299366646202,0.0008826261775512,0.0011409562972179
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",86,TRUE,1,"Male",6,"incidence",0.0004470744013172,0.000383122702421,0.0004929770860318
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",86,TRUE,1,"Male",15,"mortality",0.175329747659481,0.177837255074613,0.169198296163004
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",86,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",87,TRUE,1,"Male",5,"prevalence",0.0010299366646202,0.0008826261775512,0.0011409562972179
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",87,TRUE,1,"Male",6,"incidence",0.0004470744013172,0.000383122702421,0.0004929770860318
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",87,TRUE,1,"Male",15,"mortality",0.175329747659481,0.177837255074613,0.169198296163004
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",87,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",88,TRUE,1,"Male",5,"prevalence",0.0010299366646202,0.0008826261775512,0.0011409562972179
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",88,TRUE,1,"Male",6,"incidence",0.0004470744013172,0.000383122702421,0.0004929770860318
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",88,TRUE,1,"Male",15,"mortality",0.175329747659481,0.177837255074613,0.169198296163004
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",88,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",89,TRUE,1,"Male",5,"prevalence",0.0010299366646202,0.0008826261775512,0.0011409562972179
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",89,TRUE,1,"Male",6,"incidence",0.0004470744013172,0.000383122702421,0.0004929770860318
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",89,TRUE,1,"Male",15,"mortality",0.175329747659481,0.177837255074613,0.169198296163004
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",89,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",85,TRUE,2,"Female",5,"prevalence",0.0007158016185791,0.0005711586806061,0.0008171250929181
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",85,TRUE,2,"Female",6,"incidence",0.0004324486939343,0.0003413990485508,0.0004899696538826
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",85,TRUE,2,"Female",15,"mortality",0.347727129580401,0.344722987691493,0.338161358245208
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",85,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",86,TRUE,2,"Female",5,"prevalence",0.0007158016185791,0.0005711586806061,0.0008171250929181
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",86,TRUE,2,"Female",6,"incidence",0.0004324486939343,0.0003413990485508,0.0004899696538826
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",86,TRUE,2,"Female",15,"mortality",0.347727129580401,0.344722987691493,0.338161358245208
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",86,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",87,TRUE,2,"Female",5,"prevalence",0.0007158016185791,0.0005711586806061,0.0008171250929181
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",87,TRUE,2,"Female",6,"incidence",0.0004324486939343,0.0003413990485508,0.0004899696538826
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",87,TRUE,2,"Female",15,"mortality",0.347727129580401,0.344722987691493,0.338161358245208
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",87,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",88,TRUE,2,"Female",5,"prevalence",0.0007158016185791,0.0005711586806061,0.0008171250929181
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",88,TRUE,2,"Female",6,"incidence",0.0004324486939343,0.0003413990485508,0.0004899696538826
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",88,TRUE,2,"Female",15,"mortality",0.347727129580401,0.344722987691493,0.338161358245208
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",88,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",89,TRUE,2,"Female",5,"prevalence",0.0007158016185791,0.0005711586806061,0.0008171250929181
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",89,TRUE,2,"Female",6,"incidence",0.0004324486939343,0.0003413990485508,0.0004899696538826
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",89,TRUE,2,"Female",15,"mortality",0.347727129580401,0.344722987691493,0.338161358245208
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,31,"85-89 years",89,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",90,TRUE,1,"Male",5,"prevalence",0.0009630776377536,0.0008134109510146,0.0010495731061242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",90,TRUE,1,"Male",6,"incidence",0.0005147111304631,0.000440632126395,0.0005609889844109
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",90,TRUE,1,"Male",15,"mortality",0.239664268053867,0.242334312835587,0.237171509793713
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",90,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",91,TRUE,1,"Male",5,"prevalence",0.0009630776377536,0.0008134109510146,0.0010495731061242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",91,TRUE,1,"Male",6,"incidence",0.0005147111304631,0.000440632126395,0.0005609889844109
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",91,TRUE,1,"Male",15,"mortality",0.239664268053867,0.242334312835587,0.237171509793713
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",91,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",92,TRUE,1,"Male",5,"prevalence",0.0009630776377536,0.0008134109510146,0.0010495731061242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",92,TRUE,1,"Male",6,"incidence",0.0005147111304631,0.000440632126395,0.0005609889844109
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",92,TRUE,1,"Male",15,"mortality",0.239664268053867,0.242334312835587,0.237171509793713
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",92,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",93,TRUE,1,"Male",5,"prevalence",0.0009630776377536,0.0008134109510146,0.0010495731061242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",93,TRUE,1,"Male",6,"incidence",0.0005147111304631,0.000440632126395,0.0005609889844109
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",93,TRUE,1,"Male",15,"mortality",0.239664268053867,0.242334312835587,0.237171509793713
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",93,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",94,TRUE,1,"Male",5,"prevalence",0.0009630776377536,0.0008134109510146,0.0010495731061242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",94,TRUE,1,"Male",6,"incidence",0.0005147111304631,0.000440632126395,0.0005609889844109
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",94,TRUE,1,"Male",15,"mortality",0.239664268053867,0.242334312835587,0.237171509793713
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",94,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",90,TRUE,2,"Female",5,"prevalence",0.0006627418479931,0.0004959189484019,0.0007741719965853
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",90,TRUE,2,"Female",6,"incidence",0.0004791655139871,0.0003626855559523,0.0005508857720165
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",90,TRUE,2,"Female",15,"mortality",0.441654164620161,0.453695605049228,0.42739604123153
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",90,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",91,TRUE,2,"Female",5,"prevalence",0.0006627418479931,0.0004959189484019,0.0007741719965853
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",91,TRUE,2,"Female",6,"incidence",0.0004791655139871,0.0003626855559523,0.0005508857720165
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",91,TRUE,2,"Female",15,"mortality",0.441654164620161,0.453695605049228,0.42739604123153
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",91,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",92,TRUE,2,"Female",5,"prevalence",0.0006627418479931,0.0004959189484019,0.0007741719965853
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",92,TRUE,2,"Female",6,"incidence",0.0004791655139871,0.0003626855559523,0.0005508857720165
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",92,TRUE,2,"Female",15,"mortality",0.441654164620161,0.453695605049228,0.42739604123153
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",92,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",93,TRUE,2,"Female",5,"prevalence",0.0006627418479931,0.0004959189484019,0.0007741719965853
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",93,TRUE,2,"Female",6,"incidence",0.0004791655139871,0.0003626855559523,0.0005508857720165
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",93,TRUE,2,"Female",15,"mortality",0.441654164620161,0.453695605049228,0.42739604123153
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",93,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",94,TRUE,2,"Female",5,"prevalence",0.0006627418479931,0.0004959189484019,0.0007741719965853
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",94,TRUE,2,"Female",6,"incidence",0.0004791655139871,0.0003626855559523,0.0005508857720165
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",94,TRUE,2,"Female",15,"mortality",0.441654164620161,0.453695605049228,0.42739604123153
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,32,"90-94 years",94,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",95,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",95,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",95,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",95,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",96,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",96,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",96,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",96,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",97,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",97,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",97,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",97,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",98,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",98,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",98,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",98,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",99,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",99,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",99,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",99,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",100,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",100,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",100,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",100,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",101,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",101,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",101,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",101,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",102,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",102,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",102,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",102,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",103,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",103,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",103,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",103,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",104,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",104,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",104,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",104,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",105,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",105,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",105,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",105,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",106,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",106,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",106,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",106,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",107,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",107,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",107,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",107,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",108,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",108,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",108,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",108,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",109,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",109,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",109,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",109,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",110,TRUE,1,"Male",5,"prevalence",0.0003844132364778,0.0003140180182019,0.0004244331351408
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",110,TRUE,1,"Male",6,"incidence",0.0005555796234159,0.0004582160497125,0.0006118511577757
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",110,TRUE,1,"Male",15,"mortality",0.76424521574819,0.771372231389291,0.758999695124804
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",110,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",95,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",95,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",95,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",95,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",96,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",96,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",96,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",96,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",97,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",97,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",97,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",97,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",98,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",98,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",98,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",98,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",99,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",99,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",99,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",99,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",100,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",100,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",100,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",100,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",101,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",101,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",101,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",101,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",102,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",102,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",102,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",102,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",103,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",103,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",103,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",103,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",104,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",104,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",104,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",104,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",105,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",105,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",105,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",105,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",106,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",106,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",106,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",106,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",107,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",107,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",107,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",107,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",108,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",108,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",108,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",108,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",109,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",109,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",109,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",109,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",110,TRUE,2,"Female",5,"prevalence",0.0003881586502138,0.0002855214025456,0.0004494225927242
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",110,TRUE,2,"Female",6,"incidence",0.0006201383787609,0.0004590585864684,0.0007172128096074
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",110,TRUE,2,"Female",15,"mortality",1.06523085921866,1.07988296029733,1.04288996914739
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,235,"95+ years",110,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",0,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",0,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",0,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",0,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",0,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",0,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",0,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",0,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",2,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",2,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",2,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",2,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",3,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",3,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",3,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",3,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",4,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",4,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",4,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",4,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",2,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",2,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",2,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",2,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",3,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",3,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",3,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",3,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",4,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",4,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",4,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",4,TRUE,2,"Female",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",1,TRUE,1,"Male",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",1,TRUE,1,"Male",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",1,TRUE,1,"Male",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",1,TRUE,1,"Male",7,"remission",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",1,TRUE,2,"Female",5,"prevalence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",1,TRUE,2,"Female",6,"incidence",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",1,TRUE,2,"Female",15,"mortality",0,0,0
826,"United Kingdom of Great Britain and Northern Ireland","Gallbladder and biliary tract cancer",2021,5,"1 to 4",1,TRUE,2,"Female",7,"remission",0,0,0
